Nox4 Inhibitors

Nox4 inhibitors comprise a diverse array of compounds designed to modulate the activity of the NADPH oxidase isoform, Nox4. These inhibitors act either by directly interacting with Nox4's catalytic site or by influencing upstream signaling pathways and cellular processes that regulate Nox4-mediated reactive oxygen species (ROS) production. One prominent member of this class is GKT137831, a selective Nox4 inhibitor that directly targets the catalytic site of Nox4, effectively suppressing ROS generation. Another notable compound is VAS2870, known for its efficacy in inhibiting Nox enzymes, including Nox4. VAS2870 directly interferes with the catalytic activity of Nox4. Similarly, GKT136901 is a potent Nox4 inhibitor that operates by directly targeting and inhibiting Nox4 enzymatic activity, providing researchers with a precise tool to explore the consequences of Nox4 inhibition in various cellular contexts. ML171 is a selective small-molecule inhibitor that primarily targets Nox1 but also exhibits cross-inhibition of Nox4. By directly inhibiting Nox4 enzymatic activity, ML171 enables researchers to explore the interconnected roles of Nox1 and Nox4 in oxidative stress-related processes. VAS3947 is a Nox4-specific inhibitor that directly targets the catalytic site of Nox4, hindering ROS generation. This specificity positions VAS3947 as a valuable compound for deciphering the consequences of targeted Nox4 inhibition. The class also includes compounds such as GKT771 and GKT1210, both potent Nox4 inhibitors that directly interact with Nox4's catalytic site, modulating ROS production and providing targeted approaches for investigating Nox4 inhibition. Ebselen, recognized for its antioxidant properties, also exhibits inhibitory effects on Nox enzymes, including Nox4, by directly interacting with its catalytic site Diphenyleneiodonium (DPI) and Apocynin (CAS Number: 498-02-2) are compounds that indirectly influence Nox4 by inhibiting flavoenzymes and disrupting the assembly of the NADPH oxidase complex, respectively.